Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065000
Filing Date
2025-05-07
Accepted
2025-05-07 07:30:24
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20250331.htm   iXBRL 10-Q 2083545
2 EX-31.1 vigl-ex31_1.htm EX-31.1 19833
3 EX-31.2 vigl-ex31_2.htm EX-31.2 19787
4 EX-32.1 vigl-ex32_1.htm EX-32.1 12043
5 EX-32.2 vigl-ex32_2.htm EX-32.2 12013
  Complete submission text file 0000950170-25-065000.txt   7403839

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vigl-20250331.xsd EX-101.SCH 938939
69 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20250331_htm.xml XML 1152418
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 25919289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)